Top challenges for pharma in 2024: Lingering inflation, geopolitical tensions, continuous pressures to cut drug prices
Drug pricing will continue to remain a major challenge for the pharmaceutical industry. It was scored as the number one impediment to industry growth when healthcare professionals were asked to rate the most negative emerging regulatory and macroeconomic trends for the 2 019, 2020, 2021 and 2022 industry outlook, states Global data, a data and analytics company.
Source – ETHealth World
